The ROE as of December 2024 (TTM) for Adial Pharmaceuticals, Inc. (ADIL) is -256.25%

According to Adial Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -256.25%. This represents a change of 314.06% compared to the average of -61.89% of the last 4 quarters.

Adial Pharmaceuticals, Inc. (ADIL) Historical ROE (quarterly & annually)

How has ADIL ROE performed in the past?

The mean historical ROE of Adial Pharmaceuticals, Inc. over the last ten years is -194.40%. The current -256.25% ROE has changed 31.82% with respect to the historical average. Over the past ten years (40 quarters), ADIL's ROE was at its highest in in the June 2018 quarter at 138.56%. The ROE was at its lowest in in the March 2023 quarter at -200.78%.

Adial Pharmaceuticals, Inc. (ADIL) ROE by Quarter and Year

Discovering the peaks and valleys of Adial Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adial Pharmaceuticals, Inc. (ADIL) Average ROE

How has ADIL ROE performed in the past?

The current ROE of Adial Pharmaceuticals, Inc. (ADIL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adial Pharmaceuticals, Inc. (ADIL) ROE vs. Peers

How is ADIL’s ROE compared to its peers?

Adial Pharmaceuticals, Inc.’s ROE is greater than TransCode Therapeutics, Inc. (-649.01%), greater than Aditxt, Inc. (-431.38%), less than Reviva Pharmaceuticals Holdings, Inc. (1.15%), greater than Avenue Therapeutics, Inc. (-473.61%), greater than Applied Molecular Transport Inc. (-131.59%), greater than Catalyst Biosciences, Inc. (-63.14%), greater than Aileron Therapeutics, Inc. (-46.89%), less than Bio-Path Holdings, Inc. (2.62%), greater than Benitec Biopharma Inc. (-60.28%), greater than Hoth Therapeutics, Inc. (-89.69%), greater than Revelation Biosciences, Inc. (-311.33%), greater than NeuroBo Pharmaceuticals, Inc. (-189.12%), greater than Virax Biolabs Group Limited (-115.10%), greater than RenovoRx, Inc. (-242.57%), greater than Axcella Health Inc. (-620.40%), less than Better Therapeutics, Inc. (129.80%), greater than Pasithea Therapeutics Corp. (-81.66%), less than Onconova Therapeutics, Inc. (619.75%), greater than Diffusion Pharmaceuticals Inc. (-44.12%), greater than Aeterna Zentaris Inc. (-84.15%), greater than Tonix Pharmaceuticals Holding Corp. (-163.95%),

Build a custom stock screener for Adial Pharmaceuticals, Inc. (ADIL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adial Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adial Pharmaceuticals, Inc. (ADIL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adial Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.